[Featured Stock] Jeil Pharmaceutical Soars 24% on Pfizer Vaccine News
[Asia Economy Reporter Kum Boryeong] Jeil Pharmaceutical, considered one of the Pfizer-related stocks, showed a sharp rise in the early trading session on the 10th.
As of 9:37 a.m. that day, Jeil Pharmaceutical's stock price recorded 102,000 won, up 24.09% (19,800 won) compared to the previous close. The stock price soared to 106,000 won at one point during the session.
On the 9th (local time), the U.S. pharmaceutical company Pfizer announced that the interim results of the Phase 3 clinical trial for the novel coronavirus infection (COVID-19) vaccine, jointly developed with Germany's BioNTech, showed a prevention efficacy exceeding 90%.
Hot Picks Today
!["Stock Set to Double: This Company Smiles Every Time a Data Center Is Built [Click e-Stock]"](https://cwcontent.asiae.co.kr/asiaresize/93/2026050416112750184_1777878687.jpg)
"Stock Set to Double: This Company Smiles Every...
- "Is Yours Just Gathering Dust at Home? Millennials & Gen Z Rediscover Digicams O...
- Chicago Fed President: "Rate Hikes Needed If Productivity Expectations Overheat"
- "High-Net-Worth Investors Managing 10 Trillion Won: 'Gangnam Wealthy Also Feel F...
- “She Shouted, ‘The Rope Isn’t Tied!’... Chinese Woman Falls from 168m Cliff ...
Jeil Pharmaceutical has been grouped as a Pfizer-related stock due to CEO Seong Seok-je being a former employee of Korea Pfizer and the company selling Pfizer products.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
